Department of Chemistry and Biomedical Sciences, Linnæus University, 391 82 Kalmar, Sweden.
J Chem Inf Model. 2020 Aug 24;60(8):4005-4020. doi: 10.1021/acs.jcim.0c00544. Epub 2020 Aug 3.
FMS-like tyrosine kinase 3 (FLT3) is mutated in ∼30% of patients that suffer from acute myeloid leukemia (AML). In about 25% of all AML patients, in-frame insertions are observed in the sequence. Most of those insertions are internal tandem duplications (ITDs) of a sequence from the protein. The characteristics of such mutations in terms of length, sequence, and location were hitherto studied in different populations, but not in a comprehensive mutation database. Here, in-frame insertions into the FLT3 gene were extracted from the Catalogue of Somatic Mutations in Cancer (COSMIC) database. These were analyzed with respect to the length, location, and sequence of the mutations. Furthermore, characteristic strings (sequences) of different lengths were identified. Mutations were shown to occur most often in the juxtamembrane zipper (JM-Z) domain of FLT3, followed by the hinge domain and first tyrosine kinase domain (TKD1), upstream of the phosphate-binding loop (P-loop). Interestingly, there are specific hot spot residues where insertions are more likely to occur. The insertions vary in length between one and 67 amino acids, with the largest insertions spanning the phosphate binding loop. Insertions that occur downstream of the P-loop are shorter. Our analysis further shows that acidic and aromatic residues are enriched in the insertions. Finally, molecular dynamics simulations were run for FLT3 with ITD insertions in the hinge and tyrosine kinase domains. On the basis of the findings, a mechanism is proposed for activation by ITDs, according to which there is no direct coupling between the length of the insertion and the activity of the mutated protein. The effect of insertions on the sensitivity of FLT3 to kinase inhibitors is discussed based on our findings.
FMS 样酪氨酸激酶 3(FLT3)在约 30%的急性髓系白血病(AML)患者中发生突变。在所有 AML 患者中,约有 25%观察到框架内插入序列。这些插入序列中,大多数是蛋白质内部串联重复(ITD)序列。这些突变在长度、序列和位置上的特征以前在不同人群中进行了研究,但没有在综合突变数据库中进行研究。在这里,框架内插入 FLT3 基因是从癌症体细胞突变目录(COSMIC)数据库中提取的。对这些突变的长度、位置和序列进行了分析。此外,还确定了不同长度的特征序列。结果表明,突变最常发生在 FLT3 的跨膜拉链(JM-Z)结构域,其次是铰链结构域和第一个酪氨酸激酶结构域(TKD1),磷酸结合环(P-loop)上游。有趣的是,存在特定的热点残基,这些残基更有可能发生插入。插入长度在 1 到 67 个氨基酸之间变化,最大的插入跨越磷酸结合环。P-loop 下游的插入较短。我们的分析进一步表明,酸性和芳香族残基在插入序列中富集。最后,针对铰链和酪氨酸激酶结构域中存在 ITD 插入的 FLT3 进行了分子动力学模拟。基于这些发现,提出了一种 ITD 激活的机制,根据该机制,插入的长度与突变蛋白的活性之间没有直接耦合。根据我们的发现,讨论了插入对 FLT3 对激酶抑制剂敏感性的影响。